【市場調査レポート】肛門疾患治療のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Anorectal Disorders Treatment Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。肛門疾患治療のグローバル市場インサイト・予測（～2028年） / Global Anorectal Disorders Treatment Market Insights, Forecast to 2028 / QY2207E09218資料のイメージです。

• レポートコード：QY2207E09218
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、126ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の肛門疾患治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に肛門疾患治療の世界市場のxxx％を占める「医薬品」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の肛門疾患治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの肛門疾患治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの肛門疾患治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

肛門疾患治療のグローバル主要メーカーには、AKORN、Novartis、Mylan、GlaxoSmithKline、Ferndale Pharma Group、F. Hoffmann-La Roche、Pfizer、Takeda Pharmaceutical Company Limited、AstraZeneca、GlaxoSmithKline、Bristol-Myers Squibb Company、Eli Lilly and Company、Merck、Sun Pharmaceutical Industries、NATCO Pharma Limited、LUPIN、Teva Pharmaceutical Industries、Boehringer Ingelheim International、AbbVie、Allergan、Aboott、Bayerなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

肛門疾患治療市場は、種類と用途によって区分されます。世界の肛門疾患治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
医薬品、外科手術、その他

【用途別セグメント】
病院、専門クリニック、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 肛門疾患治療製品概要
- 種類別市場（医薬品、外科手術、その他）
- 用途別市場（病院、専門クリニック、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の肛門疾患治療販売量予測2017-2028
- 世界の肛門疾患治療売上予測2017-2028
- 肛門疾患治療の地域別販売量
- 肛門疾患治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別肛門疾患治療販売量
- 主要メーカー別肛門疾患治療売上
- 主要メーカー別肛門疾患治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（医薬品、外科手術、その他）
- 肛門疾患治療の種類別販売量
- 肛門疾患治療の種類別売上
- 肛門疾患治療の種類別価格
・用途別市場規模（病院、専門クリニック、その他）
- 肛門疾患治療の用途別販売量
- 肛門疾患治療の用途別売上
- 肛門疾患治療の用途別価格
・北米市場
- 北米の肛門疾患治療市場規模（種類別、用途別）
- 主要国別の肛門疾患治療市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの肛門疾患治療市場規模（種類別、用途別）
- 主要国別の肛門疾患治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の肛門疾患治療市場規模（種類別、用途別）
- 主要国別の肛門疾患治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の肛門疾患治療市場規模（種類別、用途別）
- 主要国別の肛門疾患治療市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの肛門疾患治療市場規模（種類別、用途別）
- 主要国別の肛門疾患治療市場規模（トルコ、サウジアラビア）
・企業情報
AKORN、Novartis、Mylan、GlaxoSmithKline、Ferndale Pharma Group、F. Hoffmann-La Roche、Pfizer、Takeda Pharmaceutical Company Limited、AstraZeneca、GlaxoSmithKline、Bristol-Myers Squibb Company、Eli Lilly and Company、Merck、Sun Pharmaceutical Industries、NATCO Pharma Limited、LUPIN、Teva Pharmaceutical Industries、Boehringer Ingelheim International、AbbVie、Allergan、Aboott、Bayer
・産業チェーン及び販売チャネル分析
- 肛門疾患治療の産業チェーン分析
- 肛門疾患治療の原材料
- 肛門疾患治療の生産プロセス
- 肛門疾患治療の販売及びマーケティング
- 肛門疾患治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 肛門疾患治療の産業動向
- 肛門疾患治療のマーケットドライバー
- 肛門疾患治療の課題
- 肛門疾患治療の阻害要因
・主な調査結果

Anorectal disorders are medical disorders that occur or develop in the rectum or the anal canal. Rectal bleeding, hemorrhoids, fissures, and polyps are the common causes of anorectal disorders. The anorectal disorders can lead to excessive pain, itching and swelling around the anus and rectum and cause discomfort.
Market Analysis and Insights: Global Anorectal Disorders Treatment Market
The global Anorectal Disorders Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Drugs accounting for % of the Anorectal Disorders Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Anorectal Disorders Treatment market size is valued at US$ million in 2021, while the North America and Europe Anorectal Disorders Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Anorectal Disorders Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anorectal Disorders Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anorectal Disorders Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anorectal Disorders Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anorectal Disorders Treatment market.
Global Anorectal Disorders Treatment Scope and Market Size
Anorectal Disorders Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Anorectal Disorders Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Drugs
Surgery
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Company
AKORN
Novartis
Mylan
GlaxoSmithKline
Ferndale Pharma Group
F. Hoffmann-La Roche
Pfizer
Takeda Pharmaceutical Company Limited
AstraZeneca
GlaxoSmithKline
Bristol-Myers Squibb Company
Eli Lilly and Company
Merck
Sun Pharmaceutical Industries
NATCO Pharma Limited
LUPIN
Teva Pharmaceutical Industries
Boehringer Ingelheim International
AbbVie
Allergan
Aboott
Bayer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anorectal Disorders Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Drugs
1.2.3 Surgery
1.2.4 Others
1.3 Market by Application
1.3.1 Global Anorectal Disorders Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anorectal Disorders Treatment Market Perspective (2017-2028)
2.2 Anorectal Disorders Treatment Growth Trends by Region
2.2.1 Anorectal Disorders Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anorectal Disorders Treatment Historic Market Size by Region (2017-2022)
2.2.3 Anorectal Disorders Treatment Forecasted Market Size by Region (2023-2028)
2.3 Anorectal Disorders Treatment Market Dynamics
2.3.1 Anorectal Disorders Treatment Industry Trends
2.3.2 Anorectal Disorders Treatment Market Drivers
2.3.3 Anorectal Disorders Treatment Market Challenges
2.3.4 Anorectal Disorders Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anorectal Disorders Treatment Players by Revenue
3.1.1 Global Top Anorectal Disorders Treatment Players by Revenue (2017-2022)
3.1.2 Global Anorectal Disorders Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Anorectal Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anorectal Disorders Treatment Revenue
3.4 Global Anorectal Disorders Treatment Market Concentration Ratio
3.4.1 Global Anorectal Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anorectal Disorders Treatment Revenue in 2021
3.5 Anorectal Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Anorectal Disorders Treatment Product Solution and Service
3.7 Date of Enter into Anorectal Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anorectal Disorders Treatment Breakdown Data by Type
4.1 Global Anorectal Disorders Treatment Historic Market Size by Type (2017-2022)
4.2 Global Anorectal Disorders Treatment Forecasted Market Size by Type (2023-2028)
5 Anorectal Disorders Treatment Breakdown Data by Application
5.1 Global Anorectal Disorders Treatment Historic Market Size by Application (2017-2022)
5.2 Global Anorectal Disorders Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Anorectal Disorders Treatment Market Size (2017-2028)
6.2 North America Anorectal Disorders Treatment Market Size by Type
6.2.1 North America Anorectal Disorders Treatment Market Size by Type (2017-2022)
6.2.2 North America Anorectal Disorders Treatment Market Size by Type (2023-2028)
6.2.3 North America Anorectal Disorders Treatment Market Share by Type (2017-2028)
6.3 North America Anorectal Disorders Treatment Market Size by Application
6.3.1 North America Anorectal Disorders Treatment Market Size by Application (2017-2022)
6.3.2 North America Anorectal Disorders Treatment Market Size by Application (2023-2028)
6.3.3 North America Anorectal Disorders Treatment Market Share by Application (2017-2028)
6.4 North America Anorectal Disorders Treatment Market Size by Country
6.4.1 North America Anorectal Disorders Treatment Market Size by Country (2017-2022)
6.4.2 North America Anorectal Disorders Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anorectal Disorders Treatment Market Size (2017-2028)
7.2 Europe Anorectal Disorders Treatment Market Size by Type
7.2.1 Europe Anorectal Disorders Treatment Market Size by Type (2017-2022)
7.2.2 Europe Anorectal Disorders Treatment Market Size by Type (2023-2028)
7.2.3 Europe Anorectal Disorders Treatment Market Share by Type (2017-2028)
7.3 Europe Anorectal Disorders Treatment Market Size by Application
7.3.1 Europe Anorectal Disorders Treatment Market Size by Application (2017-2022)
7.3.2 Europe Anorectal Disorders Treatment Market Size by Application (2023-2028)
7.3.3 Europe Anorectal Disorders Treatment Market Share by Application (2017-2028)
7.4 Europe Anorectal Disorders Treatment Market Size by Country
7.4.1 Europe Anorectal Disorders Treatment Market Size by Country (2017-2022)
7.4.2 Europe Anorectal Disorders Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anorectal Disorders Treatment Market Size (2017-2028)
8.2 Asia-Pacific Anorectal Disorders Treatment Market Size by Type
8.2.1 Asia-Pacific Anorectal Disorders Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Anorectal Disorders Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Anorectal Disorders Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Anorectal Disorders Treatment Market Size by Application
8.3.1 Asia-Pacific Anorectal Disorders Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Anorectal Disorders Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Anorectal Disorders Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Anorectal Disorders Treatment Market Size by Region
8.4.1 Asia-Pacific Anorectal Disorders Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Anorectal Disorders Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anorectal Disorders Treatment Market Size (2017-2028)
9.2 Latin America Anorectal Disorders Treatment Market Size by Type
9.2.1 Latin America Anorectal Disorders Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Anorectal Disorders Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Anorectal Disorders Treatment Market Share by Type (2017-2028)
9.3 Latin America Anorectal Disorders Treatment Market Size by Application
9.3.1 Latin America Anorectal Disorders Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Anorectal Disorders Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Anorectal Disorders Treatment Market Share by Application (2017-2028)
9.4 Latin America Anorectal Disorders Treatment Market Size by Country
9.4.1 Latin America Anorectal Disorders Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Anorectal Disorders Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anorectal Disorders Treatment Market Size (2017-2028)
10.2 Middle East & Africa Anorectal Disorders Treatment Market Size by Type
10.2.1 Middle East & Africa Anorectal Disorders Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Anorectal Disorders Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Anorectal Disorders Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Anorectal Disorders Treatment Market Size by Application
10.3.1 Middle East & Africa Anorectal Disorders Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Anorectal Disorders Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Anorectal Disorders Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Anorectal Disorders Treatment Market Size by Country
10.4.1 Middle East & Africa Anorectal Disorders Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Anorectal Disorders Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AKORN
11.1.1 AKORN Company Details
11.1.2 AKORN Business Overview
11.1.3 AKORN Anorectal Disorders Treatment Introduction
11.1.4 AKORN Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.1.5 AKORN Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Anorectal Disorders Treatment Introduction
11.2.4 Novartis Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.2.5 Novartis Recent Developments
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Anorectal Disorders Treatment Introduction
11.3.4 Mylan Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.3.5 Mylan Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Anorectal Disorders Treatment Introduction
11.4.4 GlaxoSmithKline Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Developments
11.5 Ferndale Pharma Group
11.5.1 Ferndale Pharma Group Company Details
11.5.2 Ferndale Pharma Group Business Overview
11.5.3 Ferndale Pharma Group Anorectal Disorders Treatment Introduction
11.5.4 Ferndale Pharma Group Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.5.5 Ferndale Pharma Group Recent Developments
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Company Details
11.6.2 F. Hoffmann-La Roche Business Overview
11.6.3 F. Hoffmann-La Roche Anorectal Disorders Treatment Introduction
11.6.4 F. Hoffmann-La Roche Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.6.5 F. Hoffmann-La Roche Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Anorectal Disorders Treatment Introduction
11.7.4 Pfizer Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.7.5 Pfizer Recent Developments
11.8 Takeda Pharmaceutical Company Limited
11.8.1 Takeda Pharmaceutical Company Limited Company Details
11.8.2 Takeda Pharmaceutical Company Limited Business Overview
11.8.3 Takeda Pharmaceutical Company Limited Anorectal Disorders Treatment Introduction
11.8.4 Takeda Pharmaceutical Company Limited Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.8.5 Takeda Pharmaceutical Company Limited Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Anorectal Disorders Treatment Introduction
11.9.4 AstraZeneca Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.9.5 AstraZeneca Recent Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Anorectal Disorders Treatment Introduction
11.10.4 GlaxoSmithKline Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.10.5 GlaxoSmithKline Recent Developments
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Company Details
11.11.2 Bristol-Myers Squibb Company Business Overview
11.11.3 Bristol-Myers Squibb Company Anorectal Disorders Treatment Introduction
11.11.4 Bristol-Myers Squibb Company Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.11.5 Bristol-Myers Squibb Company Recent Developments
11.12 Eli Lilly and Company
11.12.1 Eli Lilly and Company Company Details
11.12.2 Eli Lilly and Company Business Overview
11.12.3 Eli Lilly and Company Anorectal Disorders Treatment Introduction
11.12.4 Eli Lilly and Company Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.12.5 Eli Lilly and Company Recent Developments
11.13 Merck
11.13.1 Merck Company Details
11.13.2 Merck Business Overview
11.13.3 Merck Anorectal Disorders Treatment Introduction
11.13.4 Merck Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.13.5 Merck Recent Developments
11.14 Sun Pharmaceutical Industries
11.14.1 Sun Pharmaceutical Industries Company Details
11.14.2 Sun Pharmaceutical Industries Business Overview
11.14.3 Sun Pharmaceutical Industries Anorectal Disorders Treatment Introduction
11.14.4 Sun Pharmaceutical Industries Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.14.5 Sun Pharmaceutical Industries Recent Developments
11.15 NATCO Pharma Limited
11.15.1 NATCO Pharma Limited Company Details
11.15.2 NATCO Pharma Limited Business Overview
11.15.3 NATCO Pharma Limited Anorectal Disorders Treatment Introduction
11.15.4 NATCO Pharma Limited Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.15.5 NATCO Pharma Limited Recent Developments
11.16 LUPIN
11.16.1 LUPIN Company Details
11.16.2 LUPIN Business Overview
11.16.3 LUPIN Anorectal Disorders Treatment Introduction
11.16.4 LUPIN Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.16.5 LUPIN Recent Developments
11.17 Teva Pharmaceutical Industries
11.17.1 Teva Pharmaceutical Industries Company Details
11.17.2 Teva Pharmaceutical Industries Business Overview
11.17.3 Teva Pharmaceutical Industries Anorectal Disorders Treatment Introduction
11.17.4 Teva Pharmaceutical Industries Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.17.5 Teva Pharmaceutical Industries Recent Developments
11.18 Boehringer Ingelheim International
11.18.1 Boehringer Ingelheim International Company Details
11.18.2 Boehringer Ingelheim International Business Overview
11.18.3 Boehringer Ingelheim International Anorectal Disorders Treatment Introduction
11.18.4 Boehringer Ingelheim International Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.18.5 Boehringer Ingelheim International Recent Developments
11.19 AbbVie
11.19.1 AbbVie Company Details
11.19.2 AbbVie Business Overview
11.19.3 AbbVie Anorectal Disorders Treatment Introduction
11.19.4 AbbVie Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.19.5 AbbVie Recent Developments
11.20 Allergan
11.20.1 Allergan Company Details
11.20.2 Allergan Business Overview
11.20.3 Allergan Anorectal Disorders Treatment Introduction
11.20.4 Allergan Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.20.5 Allergan Recent Developments
11.21 Aboott
11.21.1 Aboott Company Details
11.21.2 Aboott Business Overview
11.21.3 Aboott Anorectal Disorders Treatment Introduction
11.21.4 Aboott Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.21.5 Aboott Recent Developments
11.22 Bayer
11.22.1 Bayer Company Details
11.22.2 Bayer Business Overview
11.22.3 Bayer Anorectal Disorders Treatment Introduction
11.22.4 Bayer Revenue in Anorectal Disorders Treatment Business (2017-2022)
11.22.5 Bayer Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Anorectal Disorders Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Drugs
Table 3. Key Players of Surgery
Table 4. Key Players of Others
Table 5. Global Anorectal Disorders Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Anorectal Disorders Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Anorectal Disorders Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Anorectal Disorders Treatment Market Share by Region (2017-2022)
Table 9. Global Anorectal Disorders Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Anorectal Disorders Treatment Market Share by Region (2023-2028)
Table 11. Anorectal Disorders Treatment Market Trends
Table 12. Anorectal Disorders Treatment Market Drivers
Table 13. Anorectal Disorders Treatment Market Challenges
Table 14. Anorectal Disorders Treatment Market Restraints
Table 15. Global Anorectal Disorders Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Anorectal Disorders Treatment Revenue Share by Players (2017-2022)
Table 17. Global Top Anorectal Disorders Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anorectal Disorders Treatment as of 2021)
Table 18. Ranking of Global Top Anorectal Disorders Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Anorectal Disorders Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Anorectal Disorders Treatment Product Solution and Service
Table 22. Date of Enter into Anorectal Disorders Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Anorectal Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Anorectal Disorders Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Anorectal Disorders Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Anorectal Disorders Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Anorectal Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Anorectal Disorders Treatment Revenue Share by Application (2017-2022)
Table 30. Global Anorectal Disorders Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Anorectal Disorders Treatment Revenue Share by Application (2023-2028)
Table 32. North America Anorectal Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Anorectal Disorders Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Anorectal Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Anorectal Disorders Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Anorectal Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Anorectal Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Anorectal Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Anorectal Disorders Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Anorectal Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Anorectal Disorders Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Anorectal Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Anorectal Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Anorectal Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Anorectal Disorders Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Anorectal Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Anorectal Disorders Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Anorectal Disorders Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Anorectal Disorders Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Anorectal Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Anorectal Disorders Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Anorectal Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Anorectal Disorders Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Anorectal Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Anorectal Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Anorectal Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Anorectal Disorders Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Anorectal Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Anorectal Disorders Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Anorectal Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Anorectal Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 62. AKORN Company Details
Table 63. AKORN Business Overview
Table 64. AKORN Anorectal Disorders Treatment Product
Table 65. AKORN Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 66. AKORN Recent Developments
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Anorectal Disorders Treatment Product
Table 70. Novartis Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 71. Novartis Recent Developments
Table 72. Mylan Company Details
Table 73. Mylan Business Overview
Table 74. Mylan Anorectal Disorders Treatment Product
Table 75. Mylan Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 76. Mylan Recent Developments
Table 77. GlaxoSmithKline Company Details
Table 78. GlaxoSmithKline Business Overview
Table 79. GlaxoSmithKline Anorectal Disorders Treatment Product
Table 80. GlaxoSmithKline Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 81. GlaxoSmithKline Recent Developments
Table 82. Ferndale Pharma Group Company Details
Table 83. Ferndale Pharma Group Business Overview
Table 84. Ferndale Pharma Group Anorectal Disorders Treatment Product
Table 85. Ferndale Pharma Group Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 86. Ferndale Pharma Group Recent Developments
Table 87. F. Hoffmann-La Roche Company Details
Table 88. F. Hoffmann-La Roche Business Overview
Table 89. F. Hoffmann-La Roche Anorectal Disorders Treatment Product
Table 90. F. Hoffmann-La Roche Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 91. F. Hoffmann-La Roche Recent Developments
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Anorectal Disorders Treatment Product
Table 95. Pfizer Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 96. Pfizer Recent Developments
Table 97. Takeda Pharmaceutical Company Limited Company Details
Table 98. Takeda Pharmaceutical Company Limited Business Overview
Table 99. Takeda Pharmaceutical Company Limited Anorectal Disorders Treatment Product
Table 100. Takeda Pharmaceutical Company Limited Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 101. Takeda Pharmaceutical Company Limited Recent Developments
Table 102. AstraZeneca Company Details
Table 103. AstraZeneca Business Overview
Table 104. AstraZeneca Anorectal Disorders Treatment Product
Table 105. AstraZeneca Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 106. AstraZeneca Recent Developments
Table 107. GlaxoSmithKline Company Details
Table 108. GlaxoSmithKline Business Overview
Table 109. GlaxoSmithKline Anorectal Disorders Treatment Product
Table 110. GlaxoSmithKline Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 111. GlaxoSmithKline Recent Developments
Table 112. Bristol-Myers Squibb Company Company Details
Table 113. Bristol-Myers Squibb Company Business Overview
Table 114. Bristol-Myers Squibb Company Anorectal Disorders Treatment Product
Table 115. Bristol-Myers Squibb Company Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 116. Bristol-Myers Squibb Company Recent Developments
Table 117. Eli Lilly and Company Company Details
Table 118. Eli Lilly and Company Business Overview
Table 119. Eli Lilly and Company Anorectal Disorders Treatment Product
Table 120. Eli Lilly and Company Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 121. Eli Lilly and Company Recent Developments
Table 122. Merck Company Details
Table 123. Merck Business Overview
Table 124. Merck Anorectal Disorders Treatment Product
Table 125. Merck Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 126. Merck Recent Developments
Table 127. Sun Pharmaceutical Industries Company Details
Table 128. Sun Pharmaceutical Industries Business Overview
Table 129. Sun Pharmaceutical Industries Anorectal Disorders Treatment Product
Table 130. Sun Pharmaceutical Industries Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 131. Sun Pharmaceutical Industries Recent Developments
Table 132. NATCO Pharma Limited Company Details
Table 133. NATCO Pharma Limited Business Overview
Table 134. NATCO Pharma Limited Anorectal Disorders Treatment Product
Table 135. NATCO Pharma Limited Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 136. NATCO Pharma Limited Recent Developments
Table 137. LUPIN Company Details
Table 138. LUPIN Business Overview
Table 139. LUPIN Anorectal Disorders Treatment Product
Table 140. LUPIN Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 141. LUPIN Recent Developments
Table 142. Teva Pharmaceutical Industries Company Details
Table 143. Teva Pharmaceutical Industries Business Overview
Table 144. Teva Pharmaceutical Industries Anorectal Disorders Treatment Product
Table 145. Teva Pharmaceutical Industries Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 146. Teva Pharmaceutical Industries Recent Developments
Table 147. Boehringer Ingelheim International Company Details
Table 148. Boehringer Ingelheim International Business Overview
Table 149. Boehringer Ingelheim International Anorectal Disorders Treatment Product
Table 150. Boehringer Ingelheim International Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 151. Boehringer Ingelheim International Recent Developments
Table 152. AbbVie Company Details
Table 153. AbbVie Business Overview
Table 154. AbbVie Anorectal Disorders Treatment Product
Table 155. AbbVie Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 156. AbbVie Recent Developments
Table 157. Allergan Company Details
Table 158. Allergan Business Overview
Table 159. Allergan Anorectal Disorders Treatment Product
Table 160. Allergan Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 161. Allergan Recent Developments
Table 162. Aboott Company Details
Table 163. Aboott Business Overview
Table 164. Aboott Anorectal Disorders Treatment Product
Table 165. Aboott Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 166. Aboott Recent Developments
Table 167. Bayer Company Details
Table 168. Bayer Business Overview
Table 169. Bayer Anorectal Disorders Treatment Product
Table 170. Bayer Revenue in Anorectal Disorders Treatment Business (2017-2022) & (US$ Million)
Table 171. Bayer Recent Developments
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anorectal Disorders Treatment Market Share by Type: 2021 VS 2028
Figure 2. Drugs Features
Figure 3. Surgery Features
Figure 4. Others Features
Figure 5. Global Anorectal Disorders Treatment Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Case Studies
Figure 7. Specialty Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Anorectal Disorders Treatment Report Years Considered
Figure 10. Global Anorectal Disorders Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Anorectal Disorders Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Anorectal Disorders Treatment Market Share by Region: 2021 VS 2028
Figure 13. Global Anorectal Disorders Treatment Market Share by Players in 2021
Figure 14. Global Top Anorectal Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anorectal Disorders Treatment as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Anorectal Disorders Treatment Revenue in 2021
Figure 16. North America Anorectal Disorders Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Anorectal Disorders Treatment Market Size Market Share by Type (2017-2028)
Figure 18. North America Anorectal Disorders Treatment Market Size Market Share by Application (2017-2028)
Figure 19. North America Anorectal Disorders Treatment Market Size Share by Country (2017-2028)
Figure 20. United States Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Anorectal Disorders Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Anorectal Disorders Treatment Market Size Market Share by Type (2017-2028)
Figure 24. Europe Anorectal Disorders Treatment Market Size Market Share by Application (2017-2028)
Figure 25. Europe Anorectal Disorders Treatment Market Size Share by Country (2017-2028)
Figure 26. Germany Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Anorectal Disorders Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Anorectal Disorders Treatment Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Anorectal Disorders Treatment Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Anorectal Disorders Treatment Market Size Share by Region (2017-2028)
Figure 36. China Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Anorectal Disorders Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Anorectal Disorders Treatment Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Anorectal Disorders Treatment Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Anorectal Disorders Treatment Market Size Share by Country (2017-2028)
Figure 46. Mexico Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Anorectal Disorders Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Anorectal Disorders Treatment Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Anorectal Disorders Treatment Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Anorectal Disorders Treatment Market Size Share by Country (2017-2028)
Figure 52. Turkey Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Anorectal Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. AKORN Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 56. Novartis Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 57. Mylan Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 59. Ferndale Pharma Group Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 61. Pfizer Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 62. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 63. AstraZeneca Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 65. Bristol-Myers Squibb Company Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 66. Eli Lilly and Company Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 67. Merck Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 68. Sun Pharmaceutical Industries Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 69. NATCO Pharma Limited Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 70. LUPIN Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 71. Teva Pharmaceutical Industries Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 72. Boehringer Ingelheim International Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 73. AbbVie Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 74. Allergan Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 75. Aboott Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 76. Bayer Revenue Growth Rate in Anorectal Disorders Treatment Business (2017-2022)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

以下、関連資料のご紹介

HPV関連疾患の世界市場2022年-2030年

HPV Associated Disorders Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030
SRT22JL0331 2022年6月 95Pages
Straits Research社発行の当調査レポートでは、世界のHPV関連疾患市場について広範囲に分析し、市場概要、関連企業、種類別、用途別、アジア太平洋市場、ヨーロッパ市場、北米市場、南米市場、中東・アフリカ市場などの地域分析を含めた項目を掲載しています。なお、当レポートに掲載されている主要企業...

世界の顎関節症（TMD）インプラント市場予測（～2028年）：金属、シリコーン、その他

Global Temporomandibular Disorders (TMD) Implants Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E8456 2022年5月 96Pages
顎関節症（TMD）インプラント市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を...

世界の遺伝性疾患薬市場予測（～2028年）：嚢胞性線維症（CF）、デュシェンヌ型筋ジストロフィー（DMD）、リソソーム蓄積症（LSD）、発作性夜間ヘモグロビン尿症（PNH）

Global Genetic Disorders Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E8831 2022年5月 91Pages
遺伝性疾患薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。

世界の顎関節症（TMD）デバイス市場予測（～2028年）：口腔副子、顎関節分析システム、インプラント、その他

Global Temporomandibular Disorders (TMD) Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E8455 2022年5月 91Pages
顎関節症（TMD）デバイス市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供...

世界の不安障害・パニック障害治療薬市場予測（～2028年）：抗うつ薬、抗不安薬

Global Anxiety and Panic Disorders Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E8741 2022年5月 98Pages
不安障害・パニック障害治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提...

世界の不安障害・パニック障害治療薬市場予測（～2028年）：抗うつ薬、抗不安薬 The Anxiety and Panic Disorders Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
HPV関連疾患の世界市場2022年-2030年 Summary: In this HPV Associated Disorders Market report, offers a comprehensive analysis of key market trends in the global HPV Associated Disorders market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and challenges which are b…
世界の顎関節症（TMD）インプラント市場予測（～2028年）：金属、シリコーン、その他 The Temporomandibular Disorders (TMD) Implants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
世界の遺伝性疾患薬市場予測（～2028年）：嚢胞性線維症（CF）、デュシェンヌ型筋ジストロフィー（DMD）、リソソーム蓄積症（LSD）、発作性夜間ヘモグロビン尿症（PNH） The Genetic Disorders Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
世界の顎関節症（TMD）デバイス市場予測（～2028年）：口腔副子、顎関節分析システム、インプラント、その他 The Temporomandibular Disorders (TMD) Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…